Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthesis and application of secondary antibody taking graphene oxide as carrier

A graphene and carrier technology, applied in the synthesis and application of secondary antibodies, can solve the problems of difficult storage and transportation, high production cost of biological secondary antibodies, poor stability, etc., to shorten the experiment time, reduce transportation and storage costs , the effect of stability improvement

Pending Publication Date: 2020-12-18
TIANJIN MEDICAL UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The artificially synthesized secondary antibody solves the problems of high production cost, difficult storage and transportation, and poor stability of biological secondary antibodies, and is suitable for common ELISA processes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis and application of secondary antibody taking graphene oxide as carrier
  • Synthesis and application of secondary antibody taking graphene oxide as carrier
  • Synthesis and application of secondary antibody taking graphene oxide as carrier

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Disperse 5-15 mg graphene oxide (GO) in 25 mL 2-morpholineethanesulfonic acid (MES) buffer (pH=6), sonicate vigorously for 2-3 h, add EDC (15 mg) and NHS (30 mg) at room temperature with gentle shaking for 12 h for activation. The activated GO was washed by centrifugation for 3 times, dispersed in PBS, added 10-25 mg of hexamethylenediamine, shaken at room temperature for 12 h, washed by centrifugation, and then dispersed in absolute ethanol (1% sodium cyanoborohydride). Add 10-25 mg of 2,6-difluoro-4-formylphenylboronic acid, shake for 6-12 h, and then add 100-200 μL of 1% bovine serum albumin (BSA) solution to passivate for 2 h to block the remaining active site. Add 100-250 μL of 5-40 mM phenolphthalein / DMSO solution, shake at room temperature for 6-12 h, centrifuge and wash 3 times, disperse in 5 mL 20 mMPBS (pH 7.4) and store until use.

Embodiment 2

[0040] Disperse 5-15 mg graphene oxide (GO) in 25 mL 2-morpholineethanesulfonic acid (MES) buffer (pH=6), sonicate vigorously for 2-3 h, add EDC (15 mg) and NHS (30 mg) at room temperature with gentle shaking for 12 h for activation. The activated GO was washed by centrifugation for 3 times, dispersed in PBS, added 10-25 mg of polyoxyethylene diamine (MW600) and shaken at room temperature for 12 h, washed by centrifugation, and then dispersed in absolute ethanol (1% cyanoboron Sodium hydride), add 10-25 mg of 2,6-difluoro-4-formylphenylboronic acid, shake for 6-12 h, then add 100-200 μL 1% bovine serum albumin (BSA) solution to passivate 2 h to block the remaining active sites. Add 100-250 μL of 5-40 mM phenolphthalein / DMSO solution, shake at room temperature for 6-12 h, centrifuge and wash 3 times, disperse in 5 mL of 20 mM PBS (pH7.4) and store until use.

Embodiment 3

[0042] Disperse 5-15 mg graphene oxide (GO) in 25 mL 2-morpholineethanesulfonic acid (MES) buffer (pH=6), sonicate vigorously for 2-3 h, add EDC (15 mg) and NHS (30 mg) at room temperature with gentle shaking for 12 h for activation. The activated GO was washed by centrifugation for 3 times, dispersed in PBS, added 10-25 mg of polyoxyethylene diamine (MW600) and shaken at room temperature for 12 h, washed by centrifugation, and then dispersed in absolute ethanol (1% cyanoboron Sodium hydride), add 10-25 mg of 2,4-difluoro-3-formylphenylboronic acid, shake for 6-12 h, then add 100-200 μL 1% bovine serum albumin (BSA) solution to passivate 2 h to block the remaining active sites. Add 10-100 μL of 5-30 mM thymolphthalein / DMSO solution, shake at room temperature for 6-12 h, centrifuge and wash 3 times, then disperse in 5 mL of 20 mM PBS (pH 7.4) and store until use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to synthesis and application of a secondary antibody with graphene oxide as a carrier. The synthesis method comprises the following synthesis steps: grafting spacer arms on graphene oxide; realizing boric acid functionalization on the graphene oxide; loading a pH sensitive color developing agent on the functional graphene oxide; carrying out the covalent binding by utilizinga boron affinity effect, and adjusting the pH value to enable the color developing agent to develop color. The present invention is capable of binding to a cis-diol glycosylated on an antibody under physiological pH conditions. The artificial secondary antibody solves the problems of high production cost, difficult storage and transportation and poor stability of a biological secondary antibody, and is suitable for a general ELISA process.

Description

technical field [0001] The invention relates to the field of biological materials, in particular to the synthesis and application of a secondary antibody with graphene oxide as a carrier. Background technique [0002] Protein is an important substance in the biological process of the body. In recent years, with the development of proteomics, people have a deeper understanding of protein. As the basis of living matter, protein is closely related to the occurrence, development, diagnosis and treatment of diseases. Therefore, quantitative detection of protein is an indispensable technical means, but the content of protein in actual samples is extremely low and has a complex matrix Interference makes protein quantification difficult. The development of enzyme-linked immunosorbent assay (ELISA) technology has basically solved this problem, but the biological reagents used in the ELISA process generally cannot be stored at low temperature for more than 6 months, and the productio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/531
CPCG01N33/531
Inventor 王涎桦董林毅段瑞孙露
Owner TIANJIN MEDICAL UNIV